FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38018411000001101: Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jan 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1149791000001119 Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1149801000001115 Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Is a Gliclazide 30mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lamzarin 30mg modified-release tablets (Key Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start